IREN Grants Co-CEOs $788M in RSUs with 6-Year Vesting
IREN has more than doubled off its 52-week low of $13.99.
Summary
IREN Ltd. has awarded its two Co-Chief Executive Officers a combined 18.2 million restricted stock units, valued at approximately $788 million, subject to a six-year vesting and holding period.
Key Events · Executive and Board Changes · IREN
-
Significant RSU Grant to Co-CEOs
Each Co-CEO, William Roberts and Daniel Roberts, received 9,099,328 restricted stock units (RSUs), totaling 18,198,656 RSUs.
-
Substantial Compensation Value
The RSU grants are valued at approximately $788 million based on the current stock price, representing about 5.1% of the company's market capitalization.
-
Long-Term Vesting and Holding Period
The RSUs are subject to a six-year vesting and holding period, with equal annual installments over four years followed by an additional two-year post-vesting holding period.
-
No Further Equity Grants Until 2031
In connection with these grants, neither Co-CEO will receive further equity incentive grants until the Company's 2031 fiscal year.
Analysis · IREN · Crypto Assets
The grant of over 18 million restricted stock units (RSUs) to the Co-CEOs, valued at approximately $788 million, represents a significant future compensation expense and potential dilution of over 5% for existing shareholders. While designed for long-term retention and alignment with a six-year vesting and holding period, the sheer magnitude of the award is notable.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 42.7% of the 487 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IREN was trading at $43.32 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $15.5B. The 52-week trading range was $13.99 to $76.87. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.